Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
24 April 2017 - P1338
In-vitro activity of dalbavancin and tedizolid against Staphylococcus spp. and Enterococcus spp.
Andrew Henderson, Cristina Gaona Álvarez, Carmen González Velasco, Jean Carlos Mendez Gonzalez, Maria Soledad Anselmo Diaz, José Miguel Manchón Castilla, Juan José Moreno Moreno, Miguel Fajardo Olivares, Ana Pérez Caballero, Paloma Martín Cordero, Rosa Sánchez Silos, Eugenio Garduno
24 April 2017 - P1352
Delafloxacin (DLX) is effective and well-tolerated in treatment of European patients with acute bacterial skin and skin structure infections (ABSSSI) versus vancomycin/aztreonam (VAN/AZ)
Lucía Boix Palop, Lajos Kemeny, Carmen Giuglea, Megan Quintas, Laura Lawrence, ShuJui Liang, Sue Cammarata
24 April 2017 - P1353
Delafloxacin (DLX) is effective and well-tolerated in treatment of diabetic (DM) patients with acute bacterial skin and skin structure infections (ABSSSI) versus vancomycin/aztreonam (VAN/AZ)
Lucía Boix Palop, Philip Giordano, William Nseir, Laura Lawrence, Yang Li, Sue Cammarata
24 April 2017 - P1354
Delafloxacin (DLX) is effective and well-tolerated in treatment of obese patients with acute bacterial skin and skin structure infections (ABSSSI) versus vancomycin/aztreonam (VAN/AZ)
Lucía Boix Palop, Shaukat Shah, Barr Baynton, Laura Lawrence, Megan Quintas, ShuJui Liang, Sue Cammarata
24 April 2017 - P1355
Delafloxacin (DLX) is effective and well-tolerated in treatment of patients with renal impairment and acute bacterial skin and skin structure infections (ABSSSI) versus vancomycin/aztreonam (VAN/AZ)
Lucía Boix Palop, Richard Beasley, Godson Oguchi, ShuJui Liang, Laura Lawrence, Sue Cammarata
24 April 2017 - P1340
New insights into tedizolid efficacy against staphylococci
Emma Cecilia Wall, Pierre DELPECH, Muna ALeryan, Brian Jones, Curtis Gemmell, Sue Lang
24 April 2017 - P1351
In vitro evaluation of delafloxacin activity when tested against contemporary ABSSSI isolates from Europe and surrounding areas (2014-2016): results from the SENTRY antimicrobial surveillance programme
Michael Huband, Jennifer Streit, Dee Shortridge, Robert Flamm
24 April 2017 - P1344
Activity of tedizolid against methicillin-susceptible and -resistant Staphylococcus aureus isolated from patients in European centres and surrounding regions
Rodrigo E. Mendes, Dee Shortridge, Helio S. Sader, Mariana Castanheira, Robert Flamm
24 April 2017 - P1343
Pharmacokinetics of oral tedizolid in diabetic patients with lower limb infections
Chunjiao Liu, Sean Stainton, Marguerite Monogue, Ashley Shepard, James Nugent, Joseph Kuti, David Nicolau
24 April 2017 - P1339
Evaluation of tedizolid against clinical isolates of Gram-positive cocci (GPC) from Singapore hospitals
Jocelyn Teo, Tze-Peng Lim, Si-Xuan Tan, Yiying Cai, Winnie Lee, Tse Hsien Koh, Li Yang Hsu, Thuan Tong Tan, Piotr Chlebicki, Andrea Lay-Hoon Kwa
24 April 2017 - P1331
In vitro activity of lefamulin against bacterial pathogens commonly causing community-acquired bacterial pneumonia (CAP): 2015 SENTRY data from Europe
Susanne Paukner, Helio S. Sader, Jennifer Streit, Robert Flamm, Steve Gelone
24 April 2017 - P1342
Comparative efficacy of linezolid (LZD) vs. tedizolid (TZD) in an experimental murine model of VRE (vancomycin-resistant enterococci) bacteraemia
Nagendra Mishra, Wessam Abdelhady, Arnold Bayer
24 April 2017 - P1334
In vitro activity of lefamulin against a global collection of respiratory pathogens from paediatric patients from the 2015 SENTRY programme
Susanne Paukner, Robert Flamm, Leonard Duncan, Steve Gelone, Helio S. Sader
24 April 2017 - P1333
In Vitro Activity of Lefamulin against S. aureus Collected from Hospitalized Patients with Bacterial Pneumonia in Europe
Susanne Paukner, Robert Flamm, Jennifer Streit, Steve Gelone, Helio S. Sader
24 April 2017 - P1350
WCK 4873 (Nafithromycin): Impact of hyper ermB induction in S. pneumoniae and S. aureus on the activity of ketolides
Sachin Bhagwat, Hemant Khande, Jaykumar Satav, Amol Kulkarni, Mahesh Patel
24 April 2017 - P1332
In Vitro Activity of Lefamulin against Staphylococccus aureus from Hospital-Acquired Pneumonia (HAP) and Community-Acquired Pneumonia (CAP) Patients in Europe
Susanne Paukner, Helio S. Sader, Robert Flamm, Leonard Duncan, Steve Gelone
24 April 2017 - P1335
Lefamulin is highly active in-vitro against multi-drug-resistant mycoplasma genitalium strains
Susanne Paukner, Jorgen Skov Jensen
24 April 2017 - P1337
IV and Oral Drug Development of the Staphylococcal-specific Antibiotic Debio 1450: Results from Formulation Finding and Multiple Ascending Dose Studies
Diamantis Kofteridis, Annick Menetrey Tacheron, Frederick Wittke, Matthias Grossmann, Azra Hussaini, Rainard Fuhr, Anne-Lise Etter, Valerie Nicolas
24 April 2017 - P1341
Efficacy of tedizolid against methicillin-resistant Staphylococcus aureus and Peptostreptococcus anaerobiuse in thigh mixed-infection mouse model
Hagihara Mao, Hiroshige Mikamo, Mao Hagihara, Hideo Kato, Naoya Nishiyama, Nobuhiro Asai, Yuseke Koizumi, Daisuke Sakanashi, Hiroyuki Suematsu, Katsuhiko Matsuura, Yuka Yamagishi
24 April 2017 - P1336
Pharmacokinetics and Safety of an Oral, Immediate-Release (IR) Tablet Formulation of Lefamulin in Fed and Fasted Healthy Subjects
Wolfgang W. Wicha, Claudia Lell, Elyse Seltzer, William Prince, Steve Gelone
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.